Kasatkar Priyanka, Shetty Shrimati, Ghosh Kanjaksha
Department of Haemostasis and Thrombosis, National Institute of Immunohaematology (ICMR), KEM Hospital, Parel, Mumbai, India.
PLoS One. 2014 Mar 27;9(3):e92575. doi: 10.1371/journal.pone.0092575. eCollection 2014.
Though von Willebrand disease (VWD) is a common coagulation disorder, due to the complexity of the molecular analysis of von Willebrand factor gene (VWF), not many reports are available from this country. Large size of the gene, heterogeneous nature of mutations and presence of a highly homologous pseudogene region are the major impediments in the genetic diagnosis of VWD. The study is aimed at unravelling the molecular pathology in a large series of VWD patients from India using an effective strategy.
We evaluated 85 unrelated Indian type 3 VWD families to identify the molecular defects using a combination of techniques i.e. PCR-RFLP, direct DNA sequencing and multiple ligation probe amplification (MLPA).
Mutations could be characterized in 77 unrelated index cases (ICs). 59 different mutations i.e. nonsense 20 (33.9%), missense 13 (22%), splice site 4 (6.8%), gene conversions 6 (10.2%), insertions 2 (3.4%), duplication 1 (1.7%), small deletions 10 (17%) and large deletions 3 (5.1%) were identified, of which 34 were novel. Two common mutations i.e. p.R1779* and p.L970del were identified in our population with founder effect. Development of alloantibodies to VWF was seen in two patients, one with nonsense mutation (p.R2434*) and the other had a large deletion spanning exons 16-52.
The molecular pathology of a large cohort of Indian VWD patients could be identified using a combination of techniques. A wide heterogeneity was observed in the nature of mutations in Indian VWD patients.
尽管血管性血友病(VWD)是一种常见的凝血障碍,但由于血管性血友病因子基因(VWF)分子分析的复杂性,该国相关报道并不多。基因规模大、突变的异质性以及高度同源假基因区域的存在是VWD基因诊断的主要障碍。本研究旨在采用有效策略,揭示大量印度VWD患者的分子病理学特征。
我们评估了85个无亲缘关系的印度3型VWD家族,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)、直接DNA测序和多重连接探针扩增(MLPA)等技术组合来鉴定分子缺陷。
在77例无亲缘关系的索引病例(ICs)中可鉴定出突变。共鉴定出59种不同的突变,即无义突变20种(33.9%)、错义突变13种(22%)、剪接位点突变4种(6.8%)、基因转换6种(10.2%)、插入突变2种(3.4%)、重复突变1种(1.7%)、小缺失突变10种(17%)和大缺失突变3种(5.1%),其中34种为新发现的突变。在我们的人群中鉴定出两种常见突变,即p.R1779和p.L970del,具有奠基者效应。两名患者出现了针对VWF的同种抗体,一名患者有无义突变(p.R2434),另一名患者有跨越外显子16至52的大缺失突变。
采用多种技术组合可鉴定大量印度VWD患者的分子病理学特征。印度VWD患者的突变性质存在广泛的异质性。